Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study.

PubWeight™: 1.93‹?› | Rank: Top 3%

🔗 View Article (PMC 2768663)

Published in Brain on September 17, 2009

Authors

Jennifer L Whitwell1, Scott A Przybelski, Stephen D Weigand, Robert J Ivnik, Prashanthi Vemuri, Jeffrey L Gunter, Matthew L Senjem, Maria M Shiung, Bradley F Boeve, David S Knopman, Joseph E Parisi, Dennis W Dickson, Ronald C Petersen, Clifford R Jack, Keith A Josephs

Author Affiliations

1: Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. whitwell.jennifer@mayo.edu

Articles citing this

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90

Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain (2012) 3.08

Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain (2012) 2.43

Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain (2012) 2.29

Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain (2011) 2.13

The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.93

Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia. Neurology (2010) 1.57

Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology (2009) 1.28

Anterior insula degeneration in frontotemporal dementia. Brain Struct Funct (2010) 1.24

Frontotemporal dementia: implications for understanding Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.23

With or without FUS, it is the anatomy that dictates the dementia phenotype. Brain (2009) 1.12

Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord (2011) 1.08

Imaging signatures of molecular pathology in behavioral variant frontotemporal dementia. J Mol Neurosci (2011) 1.03

Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease. Mov Disord (2010) 1.03

Predicting functional decline in behavioural variant frontotemporal dementia. Brain (2011) 1.00

Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology. Nat Rev Neurol (2012) 0.99

Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD. Neurology (2011) 0.99

Anatomical heterogeneity of Alzheimer disease: based on cortical thickness on MRIs. Neurology (2014) 0.99

Caudate atrophy on MRI is a characteristic feature of FTLD-FUS. Eur J Neurol (2010) 0.97

FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type. PLoS One (2013) 0.96

Self-projection and the default network in frontotemporal dementia. Nat Rev Neurol (2012) 0.95

Comprehension of insincere communication in neurodegenerative disease: lies, sarcasm, and theory of mind. Cortex (2011) 0.95

GroupICA dual regression analysis of resting state networks in a behavioral variant of frontotemporal dementia. Front Hum Neurosci (2013) 0.94

Neuropsychological assessment of patients with dementing illness. Nat Rev Neurol (2011) 0.94

Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol (2013) 0.92

Structural neuroimaging of social cognition in progressive non-fluent aphasia and behavioral variant of frontotemporal dementia. Front Hum Neurosci (2013) 0.91

Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia. PLoS One (2013) 0.88

Profiles of white matter tract pathology in frontotemporal dementia. Hum Brain Mapp (2014) 0.87

Interrater reliability of the new criteria for behavioral variant frontotemporal dementia. Neurology (2013) 0.86

Predicting survival in frontotemporal dementia with motor neuron disease. Neurology (2011) 0.86

Self-awareness in neurodegenerative disease relies on neural structures mediating reward-driven attention. Brain (2014) 0.85

Cerebellar integrity in the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One (2014) 0.85

COMT Val158Met genotype influences neurodegeneration within dopamine-innervated brain structures. Neurology (2012) 0.85

Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. Eur J Neurol (2012) 0.84

Structural MRI in frontotemporal dementia: comparisons between hippocampal volumetry, tensor-based morphometry and voxel-based morphometry. PLoS One (2012) 0.84

Frontal asymmetry in behavioral variant frontotemporal dementia: clinicoimaging and pathogenetic correlates. Neurobiol Aging (2012) 0.83

Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy. Neuroimage Clin (2013) 0.83

Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer's disease. Am J Alzheimers Dis Other Demen (2013) 0.82

Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia. Brain (2013) 0.82

Right temporal variant frontotemporal dementia with motor neuron disease. J Clin Neurosci (2011) 0.81

Functional neural correlates of emotional expression processing deficits in behavioural variant frontotemporal dementia. J Psychiatry Neurosci (2013) 0.81

Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns. Alzheimers Dement (Amst) (2015) 0.80

The behavioral variant of frontotemporal dementia: linking neuropathology to social cognition. Neurol Sci (2013) 0.80

Magnetoencephalography of frontotemporal dementia: spatiotemporally localized changes during semantic decisions. Brain (2011) 0.80

A Comparison of Magnetic Resonance Imaging and Neuropsychological Examination in the Diagnostic Distinction of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia. Front Aging Neurosci (2016) 0.80

Differential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease. Aust N Z J Psychiatry (2012) 0.79

Recent advances in the imaging of frontotemporal dementia. Curr Neurol Neurosci Rep (2012) 0.78

A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function. PLoS One (2013) 0.78

Distinct Subtypes of Behavioral Variant Frontotemporal Dementia Based on Patterns of Network Degeneration. JAMA Neurol (2016) 0.77

Neural basis of motivational approach and withdrawal behaviors in neurodegenerative disease. Brain Behav (2015) 0.77

Therapeutic and diagnostic challenges for frontotemporal dementia. Front Aging Neurosci (2014) 0.76

Focal brain atrophy in gastric bypass patients with cognitive complaints. J Clin Neurosci (2011) 0.76

Brain activation in frontotemporal and Alzheimer's dementia: a functional near-infrared spectroscopy study. Alzheimers Res Ther (2016) 0.76

Patterns of cortical thinning in nondemented Parkinson's disease patients. Mov Disord (2016) 0.76

Face shape and face identity processing in behavioral variant fronto-temporal dementia: A specific deficit for familiarity and name recognition of famous faces. Neuroimage Clin (2016) 0.76

Disrupted rich club network in behavioral variant frontotemporal dementia and early-onset Alzheimer's disease. Hum Brain Mapp (2015) 0.75

False Recognition in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease-Disinhibition or Amnesia? Front Aging Neurosci (2016) 0.75

Predicting behavioral variant frontotemporal dementia with pattern classification in multi-center structural MRI data. Neuroimage Clin (2017) 0.75

Frontotemporal dementia parkinsonism: Clinical findings in a large Iranian family. Adv Biomed Res (2015) 0.75

Imaging plus X: multimodal models of neurodegenerative disease. Curr Opin Neurol (2017) 0.75

Articles cited by this

"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74

Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage (2002) 49.90

Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03

Voxel-based morphometry--the methods. Neuroimage (2000) 34.79

Unified segmentation. Neuroimage (2005) 30.20

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77

Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging (2001) 25.22

A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging (1998) 23.54

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01

A new clinical scale for the staging of dementia. Br J Psychiatry (1982) 21.77

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging (2008) 14.68

Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature (2006) 11.59

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain (2008) 9.64

Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage (2005) 8.50

Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol (1997) 6.12

Frontal-subcortical circuits and human behavior. Arch Neurol (1993) 5.61

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry (1994) 5.40

Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17

Frontotemporal dementia: clinicopathological correlations. Ann Neurol (2006) 5.14

Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology (2002) 5.03

Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet (2006) 4.80

Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol (2008) 4.73

Clinicopathological correlates in frontotemporal dementia. Ann Neurol (2004) 4.38

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (1994) 4.24

Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol (2006) 4.24

A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol (2000) 4.22

Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology (2001) 4.10

The selective impairment of semantic memory. Q J Exp Psychol (1975) 3.63

Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology (2006) 3.60

3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain (2007) 3.53

The evolution and pathology of frontotemporal dementia. Brain (2005) 3.46

Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol (2001) 3.43

Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol (2008) 3.03

Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol (1999) 3.03

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02

Neuroanatomical correlates of behavioural disorders in dementia. Brain (2005) 2.92

What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. Brain (2004) 2.90

Memory and MRI-based hippocampal volumes in aging and AD. Neurology (2000) 2.65

Frontotemporal dementia and related disorders: deciphering the enigma. Ann Neurol (2008) 2.51

Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry (2001) 2.50

Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol (1996) 2.45

Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology (2008) 2.45

Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology (2007) 2.43

Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology (2004) 2.37

Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol (2006) 2.27

Mayo's older Americans normative studies: category fluency norms. J Clin Exp Neuropsychol (1998) 2.18

Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain (2008) 2.17

Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Arch Neurol (2005) 2.06

Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology (2006) 2.01

Frontotemporal dementia. Br J Psychiatry (2002) 1.95

Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging (2006) 1.92

Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain (2008) 1.79

Left/right asymmetry of atrophy in semantic dementia: behavioral-cognitive implications. Neurology (2003) 1.76

The temporal variant of frontotemporal dementia. Brain (1997) 1.76

MRI hippocampal volumes and memory function before and after temporal lobectomy. Neurology (1993) 1.68

Neural correlates of semantic and behavioural deficits in frontotemporal dementia. Neuroimage (2004) 1.58

Frontotemporal dementia as a neural system disease. Neurobiol Aging (2005) 1.55

Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions. Acta Neuropathol (2008) 1.49

Frontotemporal dementia (Pick's disease): clinical features and assessment. Neurology (2001) 1.48

Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology (2009) 1.48

The clinical profile of right temporal lobe atrophy. Brain (2009) 1.46

VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration. Neuroimage (2007) 1.40

Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Arch Neurol (2007) 1.39

Progressive right frontotemporal degeneration: clinical, neuropsychological and SPECT characteristics. Dementia (1993) 1.35

Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Arch Neurol (2006) 1.35

Neural correlates of executive function and working memory in the 'at-risk mental state'. Br J Psychiatry (2009) 1.29

A longitudinal study of language decline in Alzheimer's disease and frontotemporal dementia. J Int Neuropsychol Soc (2007) 1.28

Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry (2001) 1.26

Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord (2006) 1.25

Clinical features of pathologic subtypes of behavioral--variant frontotemporal dementia. Arch Neurol (2007) 1.22

Frontotemporal lobar degeneration without lobar atrophy. Arch Neurol (2006) 1.22

Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (2004) 1.19

The anatomic correlate of prosopagnosia in semantic dementia. Neurology (2008) 1.18

Apathy and disinhibition in frontotemporal dementia: Insights into their neural correlates. Neurology (2008) 1.17

Neuroanatomy of apathy and disinhibition in frontotemporal lobar degeneration. Dement Geriatr Cogn Disord (2009) 1.17

Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia. Neurology (2006) 1.16

Volumetric study of lobar atrophy in Pick complex and Alzheimer's disease. J Neurol Sci (2000) 1.09

Alzheimer's disease and frontal variant of frontotemporal dementia-- a very brief battery for cognitive and behavioural distinction. J Neurol (2005) 1.08

Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain (2006) 1.08

Neuropathology of Pick's disease. Neurology (2001) 1.05

Left frontal lobe contributions to concept formation: a quantitative MRI study of performance on the Delis-Kaplan Executive Function System Sorting Test. J Clin Exp Neuropsychol (2008) 0.95

A volumetric magnetic resonance imaging study of the amygdala in frontotemporal lobar degeneration and Alzheimer's disease. Dement Geriatr Cogn Disord (2005) 0.92

Rate of cognitive change measured by neuropsychologic test performance in 3 distinct dementia syndromes. Alzheimer Dis Assoc Disord (2007) 0.91

Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia. Alzheimer Dis Assoc Disord (2007) 0.81

Articles by these authors

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging (2008) 14.68

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol (2009) 14.42

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron (2004) 14.35

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21

Mild cognitive impairment. Lancet (2006) 10.21

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain (2008) 9.64

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol (2013) 9.43

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23

Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (2007) 8.10

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement (2005) 7.90

The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am (2005) 7.26

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain (2009) 7.20

Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain (2002) 6.85

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 6.84

Automatic classification of MR scans in Alzheimer's disease. Brain (2008) 6.71

A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39

Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol (2006) 6.20

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol (2007) 5.98

The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology (2008) 5.94

Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron (2013) 5.91

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52

Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain (2005) 5.29

Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol (2005) 5.19

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10

Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10

The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimers Dement (2006) 5.05

Mild cognitive impairment: ten years later. Arch Neurol (2009) 5.02

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85

Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol (2009) 4.73

Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol (2008) 4.73

Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol (2007) 4.68

Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66

The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol (2006) 4.56

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain (2007) 4.50

Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage (2007) 4.41

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39